Related Experiment Video
Updated: May 12, 2026

Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases
Published on: December 6, 2016
Neuroradiological Findings in Cerebral Amyloid Angiopathy with a Particular Consideration of the Boston Criteria 2.0:
Ulf Jensen-Kondering1,2, Katharina Heß3, Alexander Neumann1
1Department of Neuroradiology, University Medical Centre Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany.
Insights
Cerebral amyloid angiopathy (CAA), a common cause of brain bleeds in older adults, is diagnosed using the Boston Criteria 2.0. This review highlights key imaging findings for accurate CAA diagnosis and to prevent misdiagnosis.
Area of Science:
- Neurology
- Neuroradiology
- Pathology
Background:
- Cerebral amyloid angiopathy (CAA) is the primary cause of lobar intracranial hemorrhages in the elderly.
- CAA results from amyloid-beta fibril deposition in cerebral and leptomeningeal vessels.
- Accurate diagnosis is critical to prevent misdiagnosis.
Purpose of the Study:
- To review the diagnostic criteria for CAA, focusing on the Boston Criteria 2.0.
- To emphasize typical and suggestive neuroradiological imaging findings for CAA diagnosis.
Main Methods:
- Review of diagnostic criteria for CAA, including the Boston Criteria 2.0.
- Emphasis on neuroradiological imaging findings.
- Discussion of clinical and histopathological findings.
Main Results:
- The Boston Criteria 2.0, updated in 2022, is the current diagnostic standard for CAA.
- Neuroradiological imaging plays an expanded role in the Boston Criteria 2.0.
- Typical and other suggestive imaging findings are crucial for diagnosis.
Conclusions:
- The Boston Criteria 2.0 provides a comprehensive framework for CAA diagnosis.
- Understanding imaging findings is essential for correct application of the criteria.
- Accurate diagnosis of CAA is vital for appropriate patient management.
Abstract:
In the elderly, cerebral amyloid angiopathy (CAA) is the most common cause for intracranial lobar hemorrhages. CAA is caused by the accumulation of amyloid-β fibrils in cortical and leptomeningeal vessels. In 2022, the Boston Criteria 2.0 became the new diagnostic standard for CAA, following the Modified Boston Criteria of 2010. The diagnostic criteria are a composite of clinical, imaging and histopathological findings. In the latest version of the Boston Criteria, neuroradiological imaging findings were even expanded compared to the previous version. Crucially, the correct application of the diagnostic criteria is necessary to avoid over- and underdiagnosis. The aim of this review is to demonstrate the diagnostic criteria for CAA with an emphasis on typical imaging findings which are part of the Boston Criteria 2.0 and other imaging findings suggestive of CAA.
More Related Videos
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Imaging Studies VII: Vascular Imaging

